Portage Biotech Inc. – CSE to Issue Final Bulletin Regarding SalvaRx Acquisition

TORONTO, Feb. 8, 2019 /PRNewswire/ – (PBT.U: CSE, PTGEF: OTC Markets) – Portage Biotech Inc. (“Portage” or the “Company”) wishes to announce that due to an oversight, closing of the SalvaRx Acquisition was completed prior to obtaining final CSE approval. The Company has been advised by CSE, however, that such approval is forthcoming and will be announced through the issuance of an Exchange Bulletin. It …

Full story available on Benzinga.com

Positive Stocks
Positive Stocks Investor Awareness
About the Author
We Specialize in Covering MicroCap Stocks, Small Cap Stocks & Providing Small Cap Investor Relations / Investor Awareness - CEO Podcast & Video Cast, With Real Time Stock Alerts, Exclusive CEO interviews. Learn more with our Investing Tools, not just for the Small Cap Investor. www.positivestocks.com

Enjoy this blog? Please spread the word :)

%d bloggers like this: